Selected Cancer-Related Publications:
Grimm P, Billiet I, Bostwick D, Dicker AP, Frank S, Immerzeel J, Keyes M, Kupelian P, Lee WR, Machtens S, Mayadev J, Moran BJ, Merrick G, Millar J, Roach M, Stock R, Shinohara K, Scholz M, Weber E, Zietman A, Zelefsky M, Wong J, Wentworth S, Vera R, Langley S. Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. BJU Int. 2012 Feb;109 Suppl 1:22-9.
Hunter GK, Reddy CA, Klein EA, Kupelian P, Angermeier K, Ulchaker J, Chehade N, Altman A, Ciezki JP. Long-term (10-year) gastrointestinal and genitourinary toxicity after treatment with external beam radiotherapy, radical prostatectomy, or brachytherapy for prostate cancer. Prostate Cancer. 2012 Apr 11;2012:853487.
Santhanam AP, Min Y, Neelakkantan H, Papp N, Meeks SL, Kupelian PA. A multi-GPU real-time dose simulation software framework for lung radiotherapy. Int J Comput Assist Radiol Surg. 2012 Sep;7(5):705-19. Epub 2012 Apr 27
Tendulkar RD, Reddy CA, Stephans KL, Ciezki JP, Klein EA, Mahadevan A, Kupelian PA. Redefining high-risk prostate cancer based on distant metastases and mortality after high-dose radiotherapy with androgen deprivation therapy. Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1397-404. Epub 2011 Jun 12
Kupelian P, Meyer JL. Image-guided, adaptive radiotherapy of prostate cancer: toward new standards of radiotherapy practice. Front Radiat Ther Oncol. 2011 May 20;43:344-68. Epub 2011 May 20